For research use only. Not for therapeutic Use.
TLR7/8-IN-1 is a crystalline from of a TLR7/TLR8 inhibitor extracted from patent WO2019220390, compound 2b. TLR7/8-IN-1 can be used for the research of autoimmune disease[1].
TLR7/8-IN-1 is a crystalline from of a TLR7/TLR8 inhibitor. TLR7/8-IN-1 can be used for the research of autoimmune disease[1].
| Catalog Number | I044419 |
| CAS Number | 2205095-75-4 |
| Synonyms | (3S)-N-[4-[[5-(1,6-dimethylpyrazolo[3,4-b]pyridin-4-yl)-3-methyl-6,7-dihydro-4H-pyrazolo[4,3-c]pyridin-1-yl]methyl]-1-bicyclo[2.2.2]octanyl]morpholine-3-carboxamide |
| Molecular Formula | C29H40N8O2 |
| Purity | ≥95% |
| InChI | InChI=1S/C29H40N8O2/c1-19-14-25(21-15-31-35(3)26(21)32-19)36-12-4-24-22(16-36)20(2)34-37(24)18-28-5-8-29(9-6-28,10-7-28)33-27(38)23-17-39-13-11-30-23/h14-15,23,30H,4-13,16-18H2,1-3H3,(H,33,38)/t23-,28?,29?/m0/s1 |
| InChIKey | OXDQXRVWDYGAHX-SAVAPUMLSA-N |
| SMILES | CC1=CC(=C2C=NN(C2=N1)C)N3CCC4=C(C3)C(=NN4CC56CCC(CC5)(CC6)NC(=O)C7COCCN7)C |
| Reference | [1]. WO2019220390 |
